• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Research Progress of FAK inhibitor Yi/PharmaSources
    July 10, 2023
    Recently, Amplia Therapeutics Limited announced its FAK inhibitor AMP945 under research combined with FOLFIRINOX was effective on the preclinical model of pancreatic cancer.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service